Eton Pharmaceuticals, Inc. Common Stock (NASDAQ: ETON) last traded at $63.47, up 5.94% on the session. The quote above updates while this page is open; the figures below are drawn from Eton Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Eton Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ETON. Its market capitalisation is $1.81 billion.
Valuation measures for Eton Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.81B |
|---|---|
| Enterprise value | $1.86B |
| P/E ratio | 162.74 |
| Price / sales | 17.18 |
| Price / book | 38.94 |
| Beta | 0.15 |
Trailing-twelve-month figures tagged in Eton Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $105.59M |
|---|---|
| Net income (TTM) | $12.69M |
| EPS (TTM) | $0.390 |
| Gross margin | 57.87% |
| Operating margin | 15.44% |
| Return on equity | 27.24% |
| Cash | $26.84M |
Range and volume for ETON over the past 52 weeks.
| 52-week high | $64.00 |
|---|---|
| 52-week low | $14.27 |
| Volume | 619.8K |
| Average volume | 525.1K |
| Previous close | $59.91 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.